Overall survival (OS) by clinical risk category for high dose interleukin-2 (HD IL-2) treated metastatic renal cell cancer (RCC): Data from PROCLAIM.
- Resource Type
- Journal
- Authors
- Fishman, Mayer N.; Clark, Joseph I.; Alva, Ajjai Shivaram; Curti, Brendan D.; Agarwal, Neeraj; Hauke, Ralph J.; Mahoney, Kathleen Margaret; Moon, Helen; Treisman, Jonathan; Tykodi, Scott; Daniels, Gregory A.; Morse, Michael; Wong, Michael K. K.; Kaufman, Howard; Gregory, Nancy C.; Dutcher, Janice P.
- Source
- JOURNAL OF CLINICAL ONCOLOGY; MAY 20 2018, 36 15, 2p. Supplement: S
- Subject
- Language
- English
- ISSN
- 15277755